Holen Sie sich die Stockscreener-App
95.36
0.10%
0.095
Handel nachbörslich:
95.37
0.005
+0.01%
Schlusskurs vom Vortag:
$95.27
Offen:
$96
24-Stunden-Volumen:
93,841
Relative Volume:
0.58
Marktkapitalisierung:
$2.16B
Einnahmen:
$213.03M
Nettoeinkommen (Verlust:
$41.32M
KGV:
52.11
EPS:
1.83
Netto-Cashflow:
$33.49M
1W Leistung:
-4.95%
1M Leistung:
+15.68%
6M Leistung:
-4.55%
1J Leistung:
+7.61%
1-Tages-Spanne:
$94.77
$97.44
1-Wochen-Bereich:
$89.25
$100.03
52-Wochen-Spanne:
$71.42
$109.58
Lemaitre Vascular Inc Stock (LMAT) Company Profile
Firmenname
Lemaitre Vascular Inc
Sektor
Telefon
781-221-2266
Adresse
63 SECOND AVENUE, BURLINGTON, MA
Vergleichen Sie LMAT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LMAT
Lemaitre Vascular Inc
|
95.36 | 2.16B | 213.03M | 41.32M | 33.49M | 1.83 |
|
ISRG
Intuitive Surgical Inc
|
473.30 | 169.86B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
192.98 | 54.82B | 21.39B | 1.61B | 2.55B | 5.56 |
|
RMD
Resmed Inc
|
274.51 | 40.32B | 5.15B | 1.40B | 1.65B | 9.51 |
|
ALC
Alcon Inc
|
79.81 | 39.28B | 10.03B | 1.07B | 1.39B | 2.17 |
|
WST
West Pharmaceutical Services Inc
|
246.95 | 17.65B | 2.96B | 487.70M | 344.00M | 6.68 |
Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-06 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2025-02-28 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2025-02-28 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2025-02-13 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-10-15 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2024-08-02 | Fortgesetzt | Lake Street | Buy |
| 2024-05-31 | Fortgesetzt | ROTH MKM | Buy |
| 2024-04-26 | Hochstufung | Stifel | Hold → Buy |
| 2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Sector Weight |
| 2023-10-23 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-09-06 | Eingeleitet | Oppenheimer | Outperform |
| 2023-08-03 | Herabstufung | Jefferies | Buy → Hold |
| 2023-05-03 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2022-10-28 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2021-09-16 | Eingeleitet | Jefferies | Buy |
| 2021-02-12 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-03-16 | Hochstufung | Sidoti | Neutral → Buy |
| 2019-10-24 | Herabstufung | First Analysis Sec | Strong Buy → Outperform |
| 2019-10-24 | Hochstufung | Lake Street | Hold → Buy |
| 2019-10-14 | Hochstufung | First Analysis Sec | Outperform → Strong Buy |
| 2019-07-25 | Bestätigt | Barrington Research | Outperform |
| 2019-07-25 | Hochstufung | First Analysis Sec | Neutral → Outperform |
| 2018-10-08 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2018-10-08 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2018-06-08 | Fortgesetzt | ROTH Capital | Buy |
| 2018-04-26 | Herabstufung | Stifel | Buy → Hold |
| 2018-04-26 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2017-10-27 | Herabstufung | First Analysis Sec | Overweight → Equal-Weight |
| 2017-10-27 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2017-07-10 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2017-07-10 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2017-03-21 | Eingeleitet | First Analysis Sec | Overweight |
| 2017-02-22 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2016-09-22 | Herabstufung | Sidoti | Buy → Neutral |
| 2016-07-28 | Bestätigt | Barrington Research | Outperform |
| 2016-02-25 | Bestätigt | Barrington Research | Outperform |
Alle ansehen
Lemaitre Vascular Inc Aktie (LMAT) Neueste Nachrichten
Will LeMaitre Vascular Inc. price bounce be sustainableAnalyst Downgrade & Stock Portfolio Risk Control - Newser
LeMaitre Vascular Inc. stock daily chart insightsAnalyst Upgrade & Safe Investment Capital Preservation Plans - Newser
Will LeMaitre Vascular Inc. continue its uptrendMarket Performance Recap & Fast Gaining Stock Strategy Reports - Newser
Statistical indicators supporting LeMaitre Vascular Inc.’s strength2025 Market Overview & Trade Opportunity Analysis Reports - Newser
LeMaitre Vascular, Inc. $LMAT Stock Holdings Lifted by Credit Agricole S A - MarketBeat
Technical signs of recovery in LeMaitre Vascular Inc.Market Volume Summary & AI Enhanced Trading Alerts - Newser
AlphaQuest LLC Grows Position in LeMaitre Vascular, Inc. $LMAT - MarketBeat
Live market analysis of LeMaitre Vascular Inc.July 2025 Setups & Fast Entry Momentum Trade Alerts - Newser
Synovus Financial Corp Boosts Stake in LeMaitre Vascular, Inc. $LMAT - MarketBeat
Algert Global LLC Grows Stock Position in LeMaitre Vascular, Inc. $LMAT - MarketBeat
Key External Factors That Drive LeMaitre Vascular Inc. Stock Price MovementsWeekly Volume Report & Entry and Exit Point Strategies - Newser
How to use Fibonacci retracement on LeMaitre Vascular Inc.Quarterly Profit Report & Risk Managed Investment Strategies - Newser
Published on: 2025-08-29 14:47:05 - Newser
LeMaitre Vascular Inc. Matches Institutional Buying Filter getLinesFromResByArray error: size == 0 - newsyoung.net
Ranking LeMaitre Vascular Inc. among high performing stocks via toolsRate Cut & Daily Profit Maximizing Trade Tips - Newser
Comerica Bank Buys 7,124 Shares of LeMaitre Vascular, Inc. $LMAT - MarketBeat
What to expect from LeMaitre Vascular Inc. in the next 30 daysTrade Analysis Report & Low Drawdown Trading Strategies - Newser
Nuveen LLC Invests $4.63 Million in LeMaitre Vascular, Inc. $LMAT - MarketBeat
Chart based analysis of LeMaitre Vascular Inc. trends2025 Price Momentum & Weekly Setup with ROI Potential - Newser
Charles Schwab Investment Management Inc. Sells 9,163 Shares of LeMaitre Vascular, Inc. $LMAT - MarketBeat
LeMaitre Vascular, Inc. $LMAT Shares Sold by CW Advisors LLC - MarketBeat
LeMaitre to Participate at Upcoming Investor Conferences in September - GlobeNewswire
Finanzdaten der Lemaitre Vascular Inc-Aktie (LMAT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):